Join Our Newsletter
|
Contact
|
Glossary
Facebook
Twitter
Linkedin
MENU
MENU
Latest
The Source Blog
Key Issues
Market Consolidation
Provider Contracts
Price Transparency
Pharmaceuticals
System Reform
COVID-19 Crisis
State Action
SLIHCQ Database
Overview
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
About
The Source Team
Source Sightings
Latest
The Source Blog
Key Issues
Market Consolidation
Provider Contracts
Price Transparency
Pharmaceuticals
System Reform
COVID-19 Crisis
State Action
Overview
SLIHCQ Database
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
About
The Source Team
Source Sightings
Search
Articles & Reports
Key Issues
All
HEALTHCARE MARKETS
- Provider Network
-- Telehealth or Telemedicine
-- Scope of Practice
-- Any Willing Provider
-- Network Adequacy
-- Tiered Network or Narrow Network
- Competition
-- Antitrust Enforcement
-- Healthcare Consolidation
-- Most Favored Nation (MFN)
-- Certificate of Need (CON)
-- Certificate of Public Advantage (COPA)
-- All-or-Nothing
-- Anti-Steering or Anti-Tiering
-- Non-Compete Provision
-- Price Manipulation
-- Competitive Bidding
-- Trade Secret
- Rate Regulation
- ACA Marketplace
HEALTHCARE COSTS
- Cost Containment
-- Shared Savings or Right to Shop
-- Reference Pricing
-- Prior Authorization
-- Utilization Review
- Price Gouging
- Cost-Sharing or Out-of-Pocket Costs
- High Deductible Health Plan (HDHP)
- Health Savings Account (HSA) or Health Reimbursement Account (HRA)
- Benefit Design
- Provider Payment
-- Value-Based Payment
-- Bundled Payment
-- Global Payment or Global Budget
-- Capitation
-- Population-Based Payment
-- Shared Risk or Risk-Based Payment
-- Facility Fee
HEALTHCARE SYSTEM REFORM
- COVID-19 Crisis
- Single Payer or Multi-Payer
- Public Option
- Delivery Reform
- Quality or Value-Based Reform
- Managed Competition
- Accountable Care Organization (ACO)
- Medicaid Reform or Medicaid Waiver
- Affordable Care Act (ACA)
- Federal Reform Effort
PRICE AND QUALITY TRANSPARENCY
- All-Payer Claims Database (APCD)
- Gag Clause or Non-Disclosure Agreement
- Surprise Billing or Balance Billing
- Quality Measure
PHARMACEUTICALS
- Drug Pricing
- Drug Formulary
- Pharmacy Benefit Manager (PBM)
- Pharmacy Regulation
-- Clawback Restriction
- Biosimilar or Generic Competition
-- Generic Competition Block or Delay
- Therapeutic Substitution
- Medicaid Pharmaceuticals
- Medicare Part D
- 340B Drug Pricing Program
- Drug Importation
Jurisdiction
All
Federal
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Start Date
End Date
Congressional Budget Office
The Prices That Commercial Health Insurers and Medicare Pay for Hospitals’ and Physicians’ Services
January 20, 2022
Congressional Budget Office
Prescription Drugs: Spending, Use, and Prices
January 19, 2022
The Commonwealth Fund
State Trends in Employer Premiums and Deductibles, 2010–2020
January 12, 2022
Journal of Law, Medicine & Ethics
Promoting Competition in Drug Pricing: A Review of Recent Congressional Legislation
January 10, 2022
46brooklyn
Examining 2021’s brand drug price increases and sneaking a peak at the early price hikes of 2022
January 3, 2022
Health Affairs
ACO Investment Model Produced Savings, But The Majority Of Participants Exited When Faced With Downside Risk
January 3, 2022
Health Affairs
How Price Regulation Is Needed To Advance Market Competition
January 3, 2022
JAMA Network
How Do Commercial Insurance Plans Fare Under Proposed Prescription Drug Price Regulation?
December 23, 2021
JAMA Network
Out-of-Pocket Costs Among Patients With a New Cancer Diagnosis Enrolled in High-Deductible Health Plans vs Traditional Insurance
December 22, 2021
California Health Care Foundation
Network Adequacy Standards in California: How They Work and Why They Matter
December 16, 2021
Health Affairs
National Health Care Spending In 2020: Growth Driven By Federal Spending In Response To The COVID-19 Pandemic
December 15, 2021
NASHP
Disrupting Hospital Price Increases: Using Growth Caps in Insurance Rate Review
December 14, 2021
Journal of General Internal Medicine
Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study
December 13, 2021
Applied Health Economics and Health Policy
Effect of Competition on Generic Drug Prices
December 13, 2021
Rock Health
Consumer adoption of telemedicine in 2021
December 13, 2021
JAMA Network
Considering the Future of Price Transparency Initiatives—Information Alone Is Not Sufficient
December 13, 2021
Next
